PRINCETON, N.J.--(BUSINESS WIRE)--Cytogen Corporation (NASDAQ: CYTO) today announced that Michael D. Becker, president and chief executive officer of Cytogen, is scheduled to present a corporate overview on Thursday October 11, 2007 at 3:00 pm pacific time (6:00 pm eastern time) at the BIO Investor Forum 2007. Mr. Becker’s presentation will include an update on CAPHOSOL prescription and shipment trends. CAPHOSOL® is an advanced electrolyte solution for the treatment of oral mucositis and dry mouth that Cytogen introduced in March 2007.
